Jay Chiu concentrates his practice on complex litigation and intellectual property matters, with a focus on U.S. patent litigation, trade secret litigation, contested Patent Office proceedings, and IP licensing and counseling matters.
After more than 12 years of litigating patent infringement cases while based in the U.S., in 2013 Jay relocated to Asia to provide counseling and direct support on the ground to his Asia-based clients. Currently, he splits his time between the Greater China region and the U.S. based on case needs. In his nearly 20 years of handling all aspects of patent litigation, he has represented a number of international corporations and diverse technology clients--including computer, semiconductor, liquid crystal display, optical storage, software, self-balancing vehicles, robotic devices, biotech, supplement, container, battery, and mobile phone/telecommunication companies--in patent infringement, trade dress infringement, and trade secret actions in federal courts across the country and/or before the International Trade Commission (ITC). His patent litigation successes include several complete defense victories for his clients after trial and on summary judgment.
Jay also helps clients develop offensive and defensive patent strategies by guiding them in pre-litigation analyses and license negotiations, providing opinions of counsel, handling contested Patent Office proceedings, and managing patent portfolio development.
He has also represented clients in commercial disputes and has experience with internal investigations, FCPA, and international arbitration matters.
Jay was recently selected and recognized in the inaugural edition of The Best Lawyers® in China for both Intellectual Property and Litigation Practice (International Firms).
Prior to joining the firm, Jay was intellectual property and litigation counsel in the Hong Kong and Los Angeles offices of another international law firm.
- American Bar Association
- American Intellectual Property Law Association
- Jay has appeared as a lecturer or panelist at numerous intellectual property conferences and seminars in the Greater China region. Topics include patent litigation and damages, ITC proceedings and 337 Investigations, inter partes review, IP licensing and transfer, trade secret litigation, and FCPA. Here are some examples:
- “Preparing for and Defending U.S. Federal Court Cases and ITC 337 Investigations,” June 12, 2019, Chengdu, China
- “Preparing for and Defending 337 Investigation for Small and Medium Enterprises, June 2018,” June 14, 2018, Guangzhou, China
- “New Developments in Trade Secret Protection and 337 Investigation Latest Case Study,” June 11, 2018, Beijing, China
- “Preparing to Defend a Section 337 Investigation,” June 9, 2017, Nanjing, China
- “An Overview of Biotech IP Portfolio Management,” November 17, 2016, Taipei, Taiwan
- “Effective Defensive Strategies When Facing U.S. Patent Litigation,” August 31, 2016, Seoul, Korea
- “U.S. Post Grant Procedures,” June 13, 2016, Beijing, China
- “Effective Strategies for Chinese Companies Facing U.S. Patent Litigation,” April 1, 2015, Qingdao, China
- “Internationalization and Intellectual Property Risk Control,” May 23, 2014, Shanghai, China
- “U.S. Trade Secret Law: Issues and Best Practices for Non-U.S. Companies,” May 9, 2014, Shenzhen, China
- “Practical Strategies for Taiwanese Companies in U.S. Patent Litigation,” March 14, 2014, Taipei City, Taiwan
- “Practical Strategies for Chinese Companies in U.S. Patent Litigation,” March 7, 2014, Shenzhen, China
- “Navigating the Complexities of E-Discovery in Patent Litigation,” December 5, 2013, Shenzhen, China
- “Asia eDiscovery Exchange 2013,” June 20, 2013, Shanghai, China
- “Asia eDiscovery Exchange 2013,” June 18, 2013, Hong Kong, SAR
- “Practical Strategies for Chinese Companies in U.S. Patent Litigation,” May 14, 2013, Shenzhen, China
- “E-Discovery in Patent Litigation,” February 1, 2013, Taipei, Taiwan
- “Protecting Intellectual Property for Chinese Companies,” January 18, 2013, Beijing, China
- “Strategies for Taiwanese Companies in U.S. Patent Litigation,” October 24, 2012, Hsinchu, Taiwan